Press release
Aquigen Bio Expands Impurity Catalogue with the Launch of Atovaquone EP Impurity A - Now Available for Pharmaceutical Quality Control and Research
Product Page:
https://aquigenbio.com/product/atovaquone-ep-impurity-a/
What Is Atovaquone EP Impurity A?
Atovaquone EP Impurity A is a specified impurity listed in the European Pharmacopoeia (EP) for the active pharmaceutical ingredient (API) Atovaquone. As per regulatory norms, it is essential to identify, quantify, and control known and potential impurities to ensure the safety, efficacy, and quality of pharmaceutical products. Atovaquone is primarily used in the treatment and prevention of Pneumocystis jirovecii pneumonia and malaria, and its impurity profiling is critical in meeting international regulatory standards.
Aquigen Bio's Atovaquone EP Impurity A is a high-purity, well-characterized reference standard designed to help researchers and manufacturers perform accurate impurity quantification and validation studies during formulation and stability testing.
Why Pharmaceutical Companies Choose Aquigen Bio for Impurity Standards
Pharmaceutical impurity profiling is a highly sensitive and regulated domain. Aquigen Bio addresses this need by offering:
Pharmacopoeial Grade Impurities: Our Atovaquone EP Impurity A meets stringent EP guidelines and is suitable for use in method development, validation, stability studies, and routine quality checks.
High Purity & Characterization: We ensure >98% purity (confirmed via HPLC), and each batch comes with detailed characterization data, including NMR, Mass Spectrometry, and Chromatographic purity reports.
Reliable Batch Consistency: Our production process is optimized for batch-to-batch consistency, enabling long-term use and reproducibility of results in analytical laboratories.
Flexible Packaging: Available in a range of pack sizes suitable for both R&D and commercial scale operations.
Prompt Global Delivery: With an agile supply chain and a global network, we deliver to customers across Asia, Europe, and North America, ensuring timely availability even under tight project timelines.
To know more about
1.Atovaquone EP Impurity B -
https://aquigenbio.com/product/atovaquone-ep-impurity-b/
2.Atovaquone EP Impurity C -
https://aquigenbio.com/product/atovaquone-ep-impurity-c/
3.Atovaquone EP Impurity D -
https://aquigenbio.com/product/atovaquone-ep-impurity-d/
Applications of Atovaquone EP Impurity A
Impurity Profiling in Drug Development
Ensures identification and quantification of potential degradation products and related substances in Atovaquone drug substances and formulations.
Analytical Method Validation
A key component in establishing method sensitivity, specificity, and reproducibility as per ICH Q2 guidelines.
Stability Testing
Used in accelerated and long-term stability studies to monitor the formation and behavior of impurities over time.
Regulatory Submission Support
Facilitates the creation of complete impurity documentation for ANDA, NDA, and DMF submissions in regulated markets.
Contact:
Aquigen Bio Sciences
281/1, Plot No 41,
Hinjawadi - Pirangut Rd,
Kasar Amboli, Pirangut,
Pune, Maharashtra 412108
Phone: +91 7030123794
Email: bd@aquigenbio.com
Visit: www.aquigenbio.com
About Aquigen Bio Sciences
Aquigen Bio Sciences is the leading resource in India for Venetoclax Impurity Standards. Recognized for its unparalleled expertise in reference materials and pharmaceutical impurities, Aquigen supports researchers and manufacturers in overcoming critical challenges in impurity identification and quantification. With a steadfast commitment to scientific precision and quality, Aquigen Bio Sciences aids cutting-edge pharmaceutical innovation that ensures safer therapeutics for global healthcare.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Aquigen Bio Expands Impurity Catalogue with the Launch of Atovaquone EP Impurity A - Now Available for Pharmaceutical Quality Control and Research here
News-ID: 3998598 • Views: …
More Releases from Aquigen Bio Sciences
Deucravacitinib Impurity 1 Critical for Risk Assessment and Safety Evaluation in …
Deucravacitinib Impurity 1 plays a crucial role in the comprehensive risk assessment and safety evaluation of Active Pharmaceutical Ingredient (API) manufacturing. Deucravacitinib, a next-generation oral drug predominantly used for the treatment of moderate-to-severe plaque psoriasis, represents a groundbreaking advance in selective tyrosine kinase 2 (TYK2) inhibition.
The safety and efficacy of Deucravacitinib are deeply reliant on stringent quality control during its production, where impurities significantly influence the drug's overall performance…
Deucravacitinib Impurity 1: Critical Role in Ensuring the Safety and Efficacy of …
April 28, 2025 - Pune, India | Deucravacitinib Impurity 1, a byproduct formed during the manufacturing process of the Deucravacitinib drug, holds significant importance in pharmaceutical development. Impurities like these arise naturally as part of synthesis, storage, or transportation, and they must be carefully analyzed to mitigate risks to drug safety and efficacy. As a key element in maintaining high-quality standards, Deucravacitinib Impurity 1 plays a pivotal role in ensuring…
Vibegron Impurity 14: Enhancing Drug Safety Through Advanced Impurity Profiling …
April 18, 2025 - Pune, India | Vibegron Impurity 14 is revolutionizing the landscape of pharmaceutical impurity profiling, setting a new benchmark in ensuring drug safety and efficacy for global markets. Advanced research and highly sophisticated testing methods have catapulted this impurity into the spotlight, reinforcing its essential role in establishing impurity standards and enhancing quality control in drug formulation processes.
To Know More About Vibegron Impurity 14
https://aquigenbio.com/product/vibegron-impurity-14/
The discovery and accurate…
Ambrisentan Hydroxy Ester Impurity: The Critical Role of Impurity Analysis in Ph …
Ambrisentan Hydroxy Ester Impurity has emerged as a subject of growing interest in pharmaceutical research and development due to its implications in drug quality and safety. Impurity analysis is a cornerstone in modern pharmaceutical R&D, ensuring drug efficacy and adherence to the stringent safety standards required by global regulatory authorities. For Ambrisentan, a drug used prominently in the treatment of pulmonary arterial hypertension, impurity profiling is essential to ascertain its…
More Releases for Impurity
Medical Impurity Standards Market Growth to 2026 - Merck KGaA, LGC Standards, Th …
Medical Impurity Standards Market research report has been produced with the systematic gathering of market information for the Chemicals industry. All this information is supplied in such a way that it properly gives an explanation of various facts and figures to the business. The market data provided in this report helps to discover diverse market opportunities present worldwide for Chemicals industry. This report gives accurate information about market trends, industrial…
Impurity Pumps Market to Witness Robust Expansion by 2024– Top Key players lik …
Market Research Report Store offers a latest published report on Impurity Pumps Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
This report focuses on the key global Impurity Pumps players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Impurity Pumps with respect to individual growth…
Impurity Cleaning Machine Global Market Research Report 2025
Impurity Cleaning Machine Report by Material, Application, and Geography Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
Access more details about this report at: https://www.research2reports.com/report-instrument/impurity-cleaning-machine-market/81344
The report firstly introduced the Impurity Cleaning Machine basics: definitions, classifications, applications…
High Purity Alumina Market Outlook, Growth Prospects and Key Opportunities 2026
High Purity Alumina (HPA) Market- Snapshot
High purity aluminum oxide is often termed as high purity alumina. It is a high-value, white, granular chemical produced commercially either by treating aluminum with specific chemicals or through use of other aluminous feed stock. Some of the most commonly used processes for high purity alumina production include alkoxide process, thermal decomposition process, choline hydrolysis process, and modified Bayer process.
One of the most prominent applications…
High Purity Gases Market : Opportunities, Demand and Forecasts, 2017 – 2027
Gases having more than 99.99% concentration are known as High Purity gases. High Purity gases are most commonly used in applications where impurity control is imperative. In high purity gases, the impurity content level is usually below 0.1 ppm. Generally, high purity gases, such as hydrogen, nitrogen, oxygen, helium, krypton and argon, among others, are classified into four groups i.e. pure gases, hydrocarbon bases gases, rare gases and miscellaneous gases.…
Global Air Purification Systems Market at a CAGR of 8.39% : To Be Valued at US$ …
Press Release - 02 May2018
Global Research and Development News --
. .
"Air Purification Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024" with coming years Industries Trends, projections of Global Growth, Major key player and Case study, Review, Share, Size, Effect.
' '
– Global Air Purification Systems Market: Overview
The report studies the global air purification system market globally as well as regionally. The report…
